The effects of epigenetic modulation on secondary metabolite biosynthesis were investigated with five Aspergillus species cultured in the presence of either the DNA methyltransferase inhibitor 5-azacitidine or the histone deacetylase inhibitor vorinostat. With Aspergillus calidoustus and Aspergillus westerdijkiae, fermentation in the presence of vorinostat (100 μM) induced significant changes in secondary metabolite profile with examples of both induction and repression. We identified putative biosynthetic gene clusters for emericellamide in A. calidoustus and ochratoxin in A. westerdijkiae. A substantial induction in production levels was observed for two secondary metabolites: the diketopiperazine alkaloid phenylahistin in A. calidoustus and the polyketide penicillic acid in A. westerdijkiae, indicating the potential of epigenetic regulation for the activation of silent fungal biosynthetic pathways.
Whole genome sequencing of microorganisms has identified a vast number of biosynthetic gene clusters (BGCs) that encode for secondary metabolite production. However, the majority are silent, or are expressed at very low levels, under laboratory culture conditions [1] . One approach to the transcriptional activation of silenced genes involves epigenetics [2] . For example, inhibition of chromatin-modifying DNA methyltransferases (DNMTs) and zinc-dependent histone deacetylases (HDACs) has an activating effect upon human gene transcription, and small molecule inhibitors of these enzymes are approved for clinical use as anticancer agents [3] . In fungi, the addition of these drugs to laboratory fermentations has successfully induced secondary metabolite production in a number of Aspergillus species [4] [5] [6] [7] [8] [9] [10] [11] . Based on these precedents, and as part of our efforts to activate silent BGCs, we investigated five Aspergillus species whose published genomes contain a large number (>50) of putative BGCs as predicted by analysis using the antiSMASH software programme [12] : Aspergillus calidoustus NRRL 281, Aspergillus westerdijkiae NRRL 3174, Aspergillus bombycis NRRL 26010, Aspergillus carbonarius NRRL 369 and Aspergillus fischeri NRRL 181.
The five species were cultivated in Aspergillus complete medium (glucose 2.5% and yeast extract 0.5%) in the presence of the DNMT inhibitor 5-azacitidine (200 µM) or the HDAC inhibitor vorinostat (100 µM) for 7 days. Of the five species, the metabolite profiles of ethyl acetate extracts from A. calidoustus and A. westerdijkiae revealed significant differences in the presence of vorinostat compared with the control fermentations. We then performed a detailed analysis of the secondary metabolite profile in these two species. Six replicates of small-scale (10 ml) fermentations were carried out in Aspergillus complete medium in the presence or absence of 100 µM vorinostat. The extracts from each fermentation were characterized by LC-MS with UV detection at a single wavelength of 254 nm and electrospray ionization mass spectrometry. Data analysis through volcano plots [13] (Fig. 1 ) revealed significant global effects of vorinostat on metabolite production, with many metabolites either increased or reduced in their levels compared with control fermentations. We then compiled lists (see Supporting Information) of natural products previously isolated from these or closely related species as reported in the Dictionary of Natural Products (http://dnp.chemnetbase.com) and the Aspergillus website (https://www.aspergillus.org.uk/), and natural products predicted by antiSMASH to be produced by putative BGCs in these species. As a result, we could tentatively identify a total of five metabolites: emericellamide A, emericellamide B and phenylahistin from A. calidoustus, and ochratoxin A and penicillic acid from A. westerdijkiae. These results powerfully illustrate the 'one strain many compounds' concept [14] . Thus, the majority of metabolites observed under our specific fermentation conditions could not be readily identified. Conversely, metabolites associated with these species in the literature were undetectable under our conditions. Nevertheless, the high sensitivity of mass spectrometry and the ability to detect metabolites at low abundance enable preliminary conclusions on metabolite diversity and identity to be drawn without the need to isolate pure compounds from the extract.
We then carried out more detailed analysis, generating UV-visible spectra, MS and MS/MS fragmentation data (see Supporting Information) for the extracts. The additional data enabled us to confirm the identity of emericellamide A, emericellamide B and ochratoxin A, although the actual amounts in the small-scale fermentation were insufficient for isolation. Furthermore, antiSMASH identified putative BGCs in A. calidoustus and A. westerdijkiae (see Supporting Information) with 80% homology, respectively, to the reported emericellamide and ochratoxin BGCs in other species [15, 16] . Meanwhile, the HPLC chromatograms indicated one main metabolite each in A. calidoustus and A. westerdijkiae whose production levels were increased by the action of vorinostat ( Fig. 2 ). While the MS molecular ions and UV spectra suggested that they were phenylahistin and penicillic acid, respectively, this could not be unambiguously affirmed by MS/MS fragmentation patterns. In order to elucidate the structures of these two compounds, large-scale fermentation was performed.
The metabolite profiles of large-scale fermentations of A. calidoustus (4 l) and A. westerdijkiae (4.5 l) treated with 100 µM vorinostat were similar to the small-scale experiments ( Fig. 2 The molecular formula together with the UV spectrum (λ max 202, 233, 320 nm) and 1D/2D NMR spectra (see Supporting Information) all matched with the reported data [17] for the diketopiperazine alkaloid phenylahistin (1). Alkaloid 1 is an inhibitor of tubulin polymerization which displays in vivo antitumor activity [17, 18] , and the synthetic analogue plinabulin is currently in Phase III clinical development for the treatment of advanced non-small cell lung cancer [19] . Phylogenetically, our producing species A. calidoustus is closer to the drimane sesquiterpenoid producers Aspergillus pseudodeflectus, Aspergillus insuetus and Aspergillus keveii rather than Aspergillus ustus [20] , the previously reported source of 1. In A. ustus, 1 was isolated as a scalemic mixture from culture in solid agar medium and its production associated with conidia formation, whereas we isolated 1 as a scalemic mixture from the liquid culture of A. calidoustus. In our 4 l scale fermentation, the isolation of sufficient phenylahistin for structure elucidation would be impossible without the significant induction (tenfold in the volcano plot, Fig. 1 a Volcano plot representation of variation in metabolite profiles of A. calidoustus extracts (n = 6) (−log10 of t-test statistical p value on y-axis vs. −log2 of ion intensity ratio on x-axes; the horizontal dashed line shows where p value = 0.05). Three metabolites were identified: emericellamide A and B were reduced in production levels by vorinostat, whereas phenylahistin was increased. b Volcano plot representation of variation in metabolic profiles of A. westerdijkiae extracts (n = 6). Two metabolites were identified: ochratoxin A was reduced in production levels by vorinostat, whereas penicillic acid was increased Fig. 1 ) by vorinostat. Although we compared the genomes of A. ustus and A. calidoustus by antiSMASH, it was not possible to clearly identify a common BGC that might be responsible for phenylahistin biosynthesis.
From the large-scale fermentation of A. westerdijkiae, we isolated 162 mg of the purified major metabolite induced by vorinostat, with a molecular formula of C 8 ) . Together with the UV absorption at 224 nm and NMR spectra (Supporting Information), the data confirmed the identity of the natural product as the polyketide penicillic acid (2), first isolated from Penicillium puberulum in 1913 and later from other Penicillium and Aspergillus species [21, 22] . A broad spectrum of biological activity including antibacterial, antifungal, antiviral, antitumor and herbicidal activity has been reported for 2. It is produced in substantial amounts by Aspergillus species grown on sucrose-based media, but normally in limited or undetectable amounts in the glucose-based media that we employed [23] . We performed a large-scale (1.5 l) control fermentation without vorinostat, and were able to isolate only~1 mg of penicillic acid. Thus, the induction of penicillic acid levels by vorinostat in the large-scale fermentation was more than 50-fold and much higher than the threefold effect observed in the small-scale fermentation (Fig. 1) . While penicillic acid production was previously induced in an Aspergillus species grown in GPY medium by the addition of anthracenone [24] , the mechanism is unknown, whereas in our study we attribute it to the epigenetic effect of HDAC inhibition by vorinostat.
In summary, A. calidoustus and A. westerdijkiae undergo significant changes in secondary metabolite production upon laboratory fermentation with the HDAC inhibitor vorinostat. Both metabolite induction and repression are observed. Through analysis of putative BGCs, we could identify the likely BGCs responsible for the production of emericellamide in A. calidoustus and ochratoxin in A. westerdijkiae. The titre levels of phenylahistin (1) in A. calidoustus and penicillic acid (2) in A. westerdijkiae were substantially increased by vorinostat, illustrating the potential of epigenetic manipulation for improving the fermentation efficiency and yield of biologically active natural products.
Experimental conditions
Large-scale (8 × 500 ml in 1-l Erlenmeyer flasks) A. calidoustus and A. westerdijkiae (3 × 1500 ml in 3-l Erlenmeyer flasks) fermentations were conducted with Aspergillus complete medium containing 100 µM vorinostat and incubated at 25°C and 150 rpm. After 7 days, the culture was extracted twice with an equal volume of ethyl acetate, and the organic layers were combined and dried using a rotary evaporator. The residue was then dissolved in 250 ml of 80% MeOH and partitioned with an equal volume of hexane. After removal of the hexane, the aqueous methanol layer was dried using a rotary evaporator.
The A. calidoustus fermentation yielded 1.3 g of material that was initially separated using an automated flash chromatography system (CombiFlash Rf, Teledyne Isco) with 30 ml min −1 flow rate and a linear gradient from 30 to 100% methanol in water (in 30 min) before washing with 100% acetonitrile (for 15 min). Further purification with a semipreparative C18 column on an Agilent 1290 Infinity UHPLC system equipped with a diode array detector yielded phenylahistin (1): 0.69 mg, white powder. [α] D 25 +71 (c 0.059, MeOH, 63% ee), lit. +123 (c 0.13, MeOH) for natural product (75% ee) [17] and +278 for purified (R)enantiomer (98% ee) [18] . 1 C16 and 18) , 127.5 (C17), 37.6 (C20), 144.6 (C21), 113.9 (C22), 28 (C23 and 24). The A. westerdijkiae fermentation yielded 3.3 g of material that was separated by an automated flash chromatography system using 30 ml min −1 flow rate and a linear gradient from 10 to 100% methanol in water (in 25 min) before washing with 100% acetonitrile (for 5 min). Further purification by automated flash chromatography using 30 ml min −1 flow rate and a linear gradient from 5 to 40% methanol in water (in 30 min) yielded penicillic acid (2) 
